Clinical Trial Update: Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a daratumumab-based, response-adapted therapy for older adults with newly diagnosed multiple myeloma, with results posted in 2024. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-12-30